Caribou Biosciences, Inc.CRBUNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-144.71M
↓ 93% below average
Average (5y)
$-75.01M
Historical baseline
Range
High:$-32.89M
Low:$-144.71M
CAGR
+34.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-144.71M | -37.9% |
| 2023 | $-104.90M | -7.7% |
| 2022 | $-97.42M | -173.3% |
| 2021 | $-35.64M | -3.2% |
| 2020 | $-34.53M | -5.0% |
| 2019 | $-32.89M | - |